Tat-PTD-Modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy

Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures

(2013) Di Yu et al.   PLoS One

Virotherapy of Neuroendocrine Tumors

(2012) Magnus Essand   NEUROENDOCRINOLOGY

Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer

(2011) Daniel T. Rein et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors

(2011) D. Yu et al.   JOURNAL OF VIROLOGY

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

(2010) Sari Pesonen et al.   ACTA ONCOLOGICA

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study

(2010) J García-Castro et al.   CANCER GENE THERAPY

Neuroblastoma: Therapeutic strategies for a clinical enigma

(2010) Shakeel Modak et al.   CANCER TREATMENT REVIEWS

Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?

(2010) Ryuichi Kanai et al.   Future Oncology

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability

(2010) Justyna Leja et al.   PLoS One

Secretogranin III in human neuroendocrine tumours

(2010) Guida Maria Portela-Gomes et al.   REGULATORY PEPTIDES

Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function

(2008) Richard J. Stanton et al.   BIOTECHNIQUES

Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region

(2008) A Danielsson et al.   CANCER GENE THERAPY

Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells

(2008) L Li et al.   CELL DEATH AND DIFFERENTIATION

The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

(2008) Tom Monclair et al.   JOURNAL OF CLINICAL ONCOLOGY